OXLC
Oxford Lane Capital Corp.Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors | Q4 2025(8Q snapshot) | 2Q | $0.00 | — | — |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Oxford Lane Capital Corp.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Dec 17, 2024 — the most recent Form 4 on file — not from today.
- Form 40001213900-24-109776Dec 17, 2024
- Form 40001213900-24-109774Dec 17, 2024
- Form 40001213900-24-047259May 29, 2024
- Form 40001213900-24-047258May 29, 2024
- Form 40001213900-23-019521Mar 13, 2023
- Form 40001209191-21-047900Jul 23, 2021
- Form 40001104659-21-087035Jun 29, 2021
- Form 40001104659-21-086378Jun 28, 2021
- Form 40001104659-21-082841Jun 17, 2021
- Form 40001104659-21-052121Apr 19, 2021
- Form 40001213900-21-022059Apr 19, 2021
- Form 40001104659-21-049821Apr 13, 2021
- Form 40001567619-20-006725Mar 19, 2020
- Form 40001567619-20-006718Mar 18, 2020
- Form 40001567619-20-006386Mar 16, 2020
Fundamentals
XBRL · Oxford Lane Capital Corp.Not enough XBRL history to plot. Oxford Lane Capital Corp.hasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Oxford Lane Capital Corp. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14AProxy statementSep 4, 2025
- SC 13D5%+ ownership (activist)Nov 14, 2024
- SC 13G/AKARPUS INVESTMENT MGT / OXFORD LANE CAPITAL - SCHEDULE 13G/A(#2)Nov 13, 2024
- DEF 14AProxy statementSep 6, 2024
- 8-KMaterial eventJul 31, 2024
- SC 13G/A5%+ ownership (amended)Jul 2, 2024
- SC 13G/AKARPUS INVESTMENT MGT / OXFORD LANE CAPITAL - SCHEDULE 13G/A(#1)Feb 13, 2024
- SC 13G/A5%+ ownership (amended)Jan 9, 2024
- SC 13D5%+ ownership (activist)Dec 22, 2023
- DEF 14AProxy statementSep 8, 2023
- SC 13D5%+ ownership (activist)May 26, 2023
- SC 13GKARPUS INVESTMENT MGT / OXFORD LANE CAPITAL - SCHEDULE 13GFeb 14, 2023
- SC 13G/A5%+ ownership (amended)Feb 13, 2023
- DEF 14AProxy statementSep 7, 2022
- SC 13G/A5%+ ownership (amended)Feb 14, 2022
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q4 2025 | open | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.